insights_auto
Why is SLS down 3.17%?
Dive Deeperchevron_right
SLS:NASDAQ
Sellas Life Sciences Group Inc
$11.60
arrow_downward
-3.17%(-0.38) 1D
Sep 25, 1:18:34 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLS...
Open
$11.99
High
$12.15
Low
$11.58
Mkt. cap
2.34B
Avg. vol.
7.26M
Volume
2.26M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
Open
$11.99
High
$12.15
Low
$11.58
Mkt. cap
2.34B
Avg. vol.
7.26M
Volume
2.26M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
News stories
From web sources and news partners
Investing.com
·
5 minutes ago
Sellas reports preclinical data on CDK9 inhibitor SLS009
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorBiotechnology
Websitesellaslifesciences.com